China National Medicines Corp Ltd (600511) — Financial Flexibility Index
China National Medicines Corp Ltd (600511) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of CN¥-520.16 Million (operating CF CN¥-540.00 Million minus capex CN¥19.84 Million) represents 0% of total liabilities (CN¥15.19 Billion). Also explore China National Medicines Corp Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
China National Medicines Corp Ltd Financial Flexibility Index (2001–2024)
Historical Financial Flexibility Index trend for China National Medicines Corp Ltd across 24 annual periods. Check China National Medicines Corp Ltd (600511) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for China National Medicines Corp Ltd (2001–2024)
Year-by-year free cash flow to debt coverage for China National Medicines Corp Ltd. For the full company profile including market capitalisation, see how much is China National Medicines Corp Ltd worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.11x | CN¥1.79 Billion | CN¥1.66 Billion | CN¥15.95 Billion | ▼ -41.7% |
| 2023 | 0.19x | CN¥2.87 Billion | CN¥2.73 Billion | CN¥14.92 Billion | ▲ +4.8% |
| 2022 | 0.18x | CN¥2.52 Billion | CN¥2.40 Billion | CN¥13.75 Billion | ▲ +17.4% |
| 2021 | 0.16x | CN¥2.05 Billion | CN¥1.96 Billion | CN¥13.12 Billion | ▲ +34.8% |
| 2020 | 0.12x | CN¥1.37 Billion | CN¥1.30 Billion | CN¥11.81 Billion | ▼ -25.0% |
| 2019 | 0.15x | CN¥1.86 Billion | CN¥1.78 Billion | CN¥12.03 Billion | ▲ +51.4% |
| 2018 | 0.10x | CN¥1.11 Billion | CN¥981.65 Million | CN¥10.90 Billion | ▼ -4.6% |
| 2017 | 0.11x | CN¥1.15 Billion | CN¥1.07 Billion | CN¥10.71 Billion | ▼ -42.5% |
| 2016 | 0.19x | CN¥631.13 Million | CN¥591.25 Million | CN¥3.38 Billion | ▲ +11.5% |
| 2015 | 0.17x | CN¥508.75 Million | CN¥440.29 Million | CN¥3.04 Billion | ▲ +34.7% |
| 2014 | 0.12x | CN¥367.17 Million | CN¥218.94 Million | CN¥2.96 Billion | ▲ +16.5% |
| 2013 | 0.11x | CN¥307.22 Million | CN¥185.56 Million | CN¥2.88 Billion | ▼ -19.4% |
| 2012 | 0.13x | CN¥355.52 Million | CN¥185.87 Million | CN¥2.69 Billion | ▲ +185.6% |
| 2011 | -0.15x | CN¥-311.60 Million | CN¥-370.56 Million | CN¥2.02 Billion | ▼ -192.4% |
| 2010 | 0.17x | CN¥342.30 Million | CN¥318.21 Million | CN¥2.05 Billion | ▲ +1.9% |
| 2009 | 0.16x | CN¥277.51 Million | CN¥255.18 Million | CN¥1.69 Billion | ▼ -20.7% |
| 2008 | 0.21x | CN¥233.30 Million | CN¥217.10 Million | CN¥1.13 Billion | ▲ +188.6% |
| 2007 | 0.07x | CN¥88.09 Million | CN¥79.48 Million | CN¥1.23 Billion | ▼ -62.0% |
| 2006 | 0.19x | CN¥145.31 Million | CN¥121.50 Million | CN¥771.05 Million | ▲ +7.2% |
| 2005 | 0.18x | CN¥133.44 Million | CN¥92.20 Million | CN¥759.27 Million | ▼ -9.1% |
| 2004 | 0.19x | CN¥136.26 Million | CN¥49.18 Million | CN¥704.48 Million | ▲ +31.1% |
| 2003 | 0.15x | CN¥91.44 Million | CN¥526.15K | CN¥619.80 Million | ▲ +105.2% |
| 2002 | 0.07x | CN¥29.38 Million | CN¥15.19 Million | CN¥408.75 Million | ▲ +381.7% |
| 2001 | -0.03x | CN¥-7.68 Million | CN¥-11.80 Million | CN¥300.99 Million | — |